The Pharmaceuticals in Dosage Market Size Value Per Capita in South Africa has demonstrated a complex pattern from 2012 to 2022. The market saw a significant drop from 135.91 in 2012 to 107.11 in 2014. However, it rebounded slightly but inconsistently, reaching 125.75 in 2021 before declining again to 119.43 in 2022. The year-on-year variation between 2021 and 2022 saw a slight decline of around 5%. On the other hand, analyzing the last two iterations shows steady yet fluctuating trends. The compound annual growth rate (CAGR) over the past five years suggests mild growth, depicting a nuanced but overall slow-progressing market.
Looking ahead, future trends to watch include potential market stabilization with emerging healthcare policies and broader access to essential medicines. Increasing investments in healthcare infrastructure and innovations in pharmaceuticals could drive market growth. Additionally, monitoring the impact of socioeconomic factors and global health events on consumption patterns will be crucial.
How does South Africa rank in Pharmaceuticals in Dosage Market Size Value Per Capita?
| # | 59 Countries | US Dollars Per Capita | Last Year | |||
|---|---|---|---|---|---|---|
| 1 | 1 Italy | 1,580 | 2023 | View data | ||
| 2 | 2 Germany | 1,460 | 2023 | View data | ||
| 3 | 3 Denmark | 1,300 | 2023 | View data | ||
| 4 | 4 Iceland | 1,220 | 2023 | View data | ||
| 5 | 5 Norway | 1,070 | 2023 | View data | ||
| 35 | 35 Armenia | 141.96 | 2023 | View data | ||
| 36 | 36 Honduras | 126.46 | 2023 | View data | ||
| 37 | 37 South Africa | 117.86 | 2023 | |||
| 38 | 38 Brazil | 115.83 | 2023 | View data | ||
| 39 | 39 Malaysia | 114.42 | 2023 | View data | ||
